Welspun Enterprises Intrinsic Value
WELENT • Construction
Current Stock Price
₹439.20
Primary Intrinsic Value
₹317.28
Market Cap
₹6017 Cr
-27.8%
Downside
Median Value
₹317.28
Value Range
₹169 - ₹343
Assessment
Trading Above Calculated Value
Safety Margin
-38.4%
WELENT Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹317.28 | ₹253.82 - ₹380.74 | -27.8% | EPS: ₹26.44, Sector P/E: 12x |
| Book Value Method | asset | ₹197.74 | ₹177.97 - ₹217.51 | -55.0% | Book Value/Share: ₹197.74, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹188.26 | ₹169.43 - ₹207.09 | -57.1% | Revenue/Share: ₹235.33, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹339.85 | ₹305.87 - ₹373.84 | -22.6% | EBITDA: ₹776.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹342.06 | ₹273.65 - ₹410.47 | -22.1% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹169.22 | ₹152.30 - ₹186.14 | -61.5% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹217.87 | ₹196.08 - ₹239.66 | -50.4% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹343.36 | ₹309.02 - ₹377.70 | -21.8% | ROE: 14.5%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹342.98 | ₹308.68 - ₹377.28 | -21.9% | EPS: ₹26.44, BVPS: ₹197.74 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
WELENT Intrinsic Value Analysis
What is the intrinsic value of WELENT?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Welspun Enterprises (WELENT) is ₹317.28 (median value). With the current market price of ₹439.20, this represents a -27.8% variance from our estimated fair value.
The valuation range spans from ₹169.22 to ₹343.36, indicating ₹169.22 - ₹343.36.
Is WELENT undervalued or overvalued?
Based on our multi-method analysis, Welspun Enterprises (WELENT) appears to be trading above calculated value by approximately 27.8%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 2.47 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 14.5% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 22.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.53x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Welspun Enterprises
Additional stock information and data for WELENT
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-274 Cr | ₹-283 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-345 Cr | ₹-374 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹345 Cr | ₹345 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹287 Cr | ₹44 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹9 Cr | ₹-450 Cr | Positive Operating Cash Flow | 6/10 |